Sedation and neuromuscular blockade in paediatric intensive care: A review of current practice in the UK

Paediatric Anaesthesia

Volumn 13, Issue 2, 2003, Pages 147-151

  Playfor, Stephen D ^a   Thomas, David A ^b   Choonara, Imti ^c  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Critical care; Intensive care; Midazolam; Neuromuscular blocking agents; Paediatrics; Sedation

Indexed keywords

MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; SEDATIVE AGENT; VECURONIUM;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; CRITICAL ILLNESS; HUMAN; INTENSIVE CARE; NEUROMUSCULAR BLOCKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SEDATION; UNITED KINGDOM;

CHILD; CHILD, PRESCHOOL; CONSCIOUS SEDATION; DRUG UTILIZATION; FEMALE; GREAT BRITAIN; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS, PEDIATRIC; MALE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 0037282656     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00989.x     Document Type: Article

References (13)

1. Matthews AJ. An audit of sedation, analgesia and muscle relaxation in paediatric intensive care in the United Kingdom. Paed Anaesth 1993; 3: 107-115.
2. Marx CM, Rosenberg DI, Ambuel B et al. Pediatric intensive care sedation: survey of fellowship training programmes. Pediatrics 1993; 91; 369-378.
3. Ambuel B, Hamlett KW, Marx CM et al. Assessing distress in pediatric intensive care environments: the COMFORT Scale. J Pediatr Psychol 1992; 17: 95-109.
4. Martin LD, Bratton SL, O'Rourke PP. Clinical uses and controversies of neuromuscular blocking agents in infants and children. Crit Care Med 1999; 27: 1358-1368.
5. Maze M, Tranquill W. Alpha-2 agonists: defining their role in clinical anesthesia. Anesthesiology 1991; 74: 581-605.
6. Watt I, Ledingham IMCA. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39: 973-981.
7. Parke TJ, Stevens JE, Rice ASC et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616.
8. Reed MD, Blumer JL. Propofol bashing: the time to stop is now! Crit Care Med 1996; 24: 175-176.
9. Bray RJ. Propofol infusion syndrome in children. Paed Anaesth 1998; 8: 491-499.
10. Murray MM, Cowen J, DeBlock H et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30: 142-156.
11. Rudis MI, Sikora CA, Angus E et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 1997; 25: 575-583.
12. Playfor SD, Thomas DA, Choonara I. The effect of induced hypothermia on the duration of action of atracurium when given by infusion to critically ill children. Paed Anaesth 2000; 10: 83-88.
13. Jacobi J, Fraser GL, Coursin DB et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30: 119-136.